Amarantus anticipates reporting final top-line data of its

New Post Public Reply Private Reply Replies (1) Message Board
jpetroinc Mutai803 #13540
Quote:
Amarantus anticipates reporting final top-line data of its LP-002 clinical study to assess LymPro's predictive value in diagnosing mild to severe Alzheimer's disease patients by the end of 2014.

(only 6 trading days left - why run it down to the wire)

Amarantus intends to publish data from this study, as well as previously reported data, at prestigious scientific congresses and in peer-reviewed journals throughout the course of 2015.

This additional data will then be useful in making a determination regarding which version of LymPro (V-1 or V-2) Amarantus will launch under the CLIA designation for marketing to the broader medical community in the US in 2015.

(final selection taking much longer than initially suspected)


Great strides here, but we need revenue desperately - why no work orders from ICON's BP rolodex........

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

1031 Specialists Takes Tax Deferral to Public TV

Updated Category News Views 100

A tax rule most people ignore is getting a television spotlight. 1031 Specialists says it will appear on All Access with Andy Garcia, an educational series distributed to Public Television stations nationwide, to explain the 1031 exchange and its role in real estate investing. That is a sensible bit of exposure for a niche business built around a topic investors tend to...

Continue Reading
Boston Scientific Loads Debt Cannon for Penumbra Deal

Updated Category News Views 128

A Very Large Financing Cart Rolled Out Boston Scientific just put an enormous stack of paper into the market, and nobody should mistake this for routine housekeeping. The company priced $3.0 billion of U.S. dollar senior notes and €4.25 billion of euro notes, with proceeds earmarked chiefly for the cash portion of its proposed Penumbra acquisition, alongside cash on...

Continue Reading
BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 96

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
Action1's 3,688% Growth Puts Patching on Investor Maps

Updated Category News Views 105

Patch Management Finally Gets Some Respect Nothing makes a security buyer flinch faster than a machine carrying a known vulnerability for weeks, and Action1 has plainly found that nerve. The Houston-based autonomous endpoint management company says it was the fastest-growing endpoint management vendor on Deloitte's 2026 Technology Fast 500 for the second consecutive year,...

Continue Reading
A. O. Smith's Sustainability Scorecard Has Real Teeth

Updated Category News Views 130

Numbers finally showed up wearing work boots in A. O. Smith’s latest sustainability report. The company says it beat every one of its three environmental targets, and the gaps were not the sort of rounding-error victories corporate communications teams love to polish until they shine. For investors following NYSE:AOS, that deserves a look—not a standing ovation, but a...

Continue Reading
GreenTree Faces Softer Rooms, Debt and NYSE Deadline

Updated Category News Views 6

A hotel operator can post positive earnings and still leave shareholders with a nasty headache, and GreenTree's third quarter is that kind of report. NYSE:GHG produced RMB243.0 million in revenue, down 22.2% from a year earlier, while net income slipped to RMB49.3 million from RMB59.0 million. This was not a one-line stumble. Room pricing, occupancy, franchise economics...

Continue Reading
BreakBio's New CSO Adds Vaccine Trial Credibility in Cancer

Updated Category News Views 156

Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...

Continue Reading
Fromm Day Marks 50 Years of Learning and Connection

Updated Category News Views 88

A city proclamation can be fluffy civic confetti, but this one lands differently. San Francisco declared Nov. 14, 2026, Fromm Day as the Fromm Institute for Lifelong Learning marked its 50th anniversary, and the underlying story is sturdier than a ceremonial photo op. A program that began in 1976 expecting roughly 50 people at an open house drew about 150 students in its...

Continue Reading
Wenge AI Removes a Small Friction Point for ScienceOra

Updated Category News Views 84

Scientific software rarely loses users because the underlying model is too clever; it loses them because getting through the front door is a nuisance. Wenge AI has addressed that unglamorous problem by adding Google and Apple sign-in options to the international version of ScienceOra, its AI-powered research and decision-support platform. This is not the sort of...

Continue Reading
NEWWAVE Turns 15 and Chases a Bigger Tech Partner Role

Updated Category News Views 97

Fifteen years is about when an outsourced engineering shop has to prove it can be more than extra hands on a keyboard. NEWWAVE’s new identity and “Trusted Technology Partner” positioning are an attempt to make that jump: from carrying out software work to helping clients decide what work ought to be done, then sticking around after launch. It is a sensible ambition,...

Continue Reading

Top 5 Most Recently Viewed Articles

ELITE Solar Achieves Gold Rating for Exceptional Sustainability

Updated Category News Views 105

ELITE Solar Earns Prestigious EcoVadis Gold Medal ELITE Solar, a renowned global manufacturer in the solar industry, proudly announces its latest achievement: the EcoVadis Gold Medal for sustainability performance. This esteemed recognition places the company among the top 5% of organizations worldwide evaluated by EcoVadis, a well-respected platform known for its...

Continue Reading
Zelluna ASA's New Share Issuance for Strategic Development

Updated Category News Views 429

Introduction to Zelluna ASA's Share Issuance Zelluna ASA has taken a significant step forward by announcing the issuance of new shares. This move has been orchestrated through a resolution made by the Company's Annual General Meeting. The decision allows the Board of Directors to issue shares, each priced at NOK 26. The primary goal is to settle an option exercise fee...

Continue Reading
Nokia's Strategic Share Buyback: Insights and Impact

Updated Category News Views 90

Nokia's Recent Share Repurchase Initiative Nokia Corporation, a transformative technology leader, recently took significant steps in its financial strategy by executing a share buyback program. This move aims not only to strengthen the company's market position but also to return approximately EUR 600 million in cash to its shareholders over a defined period....

Continue Reading
Berman Tabacco Expands Legal Action Against Outset Medical, Inc.

Updated Category News Views 176

Berman Tabacco Expands Legal Action Against Outset Medical, Inc. Berman Tabacco is making headlines with a significant development in its legal efforts concerning Outset Medical, Inc. This new class action complaint has been lodged in the United States District Court for the Northern District of California against Outset Medical, Inc. (NASDAQ: OM) and specific current and...

Continue Reading
New York City Rental Surge: Bronx Hits Over 61% Increase

Updated Category News Views 304

NYC Rental Prices Surge Significantly Newly released data highlights a troubling trend as rental prices in New York City continue to rise sharply, now impacting the affordability of living for many residents. The Bronx has reported a staggering rent increase of over 61% since the last six years, marking it as the borough with the steepest rise in rental costs. Current...

Continue Reading